Skip to main content
Erschienen in: European Journal of Medical Research 11/2010

01.12.2010 | Research

Prognostic value of hedgehog signal component expressions in hepatoblastoma patients

verfasst von: Ying-Cun Li, Yu-Hua Deng, Zhen-Hua Guo, Ming-Man Zhang, Jin Zhu, Chon-Lun Pu, Chun-Ping Xiang, Chun-Bao Guo

Erschienen in: European Journal of Medical Research | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

Activation of hedgehog (Hh) pathway has been implicated in the development of human malignancies. Hh as well as related downstream target genes has been extensively studied in many kinds of malignant tumours for clinical diagnostic or prognostic utilities. This study aimed at investigating whether Hh molecules provides a molecular marker of hepatoblastoma malignancy.

Methods

We obtained tissue sections from 32 patients with hepatoblastoma as well as cholestasis and normal control. Immunohistochemical analysis were performed to determine Hh signal components in human hepatoblastoma. The prognostic significance of single expression of Hh signal components were evaluated using Cox proportional hazards regression models and Kaplan-Meier survival analysis for statistical analysis.

Results

Expression of Hh signal components showed an increase in hepatoblastoma compared with chole stasis and normal tissues. There was a positive correlation between Smo or Gli1 expression and tumor clinicopathological features, such as histological type, tumor grade, tumor size and clinical stage. Both Smo or Gli1 protein high expression was significantly associated with poor prognosis by univariate analyses and multivariate analyses.

Conclusions

Abnormal Hh signaling activation plays important roles in the malignant potential of hepatoblastoma. Gli1 expression is an independent prognostic marker.
Literatur
1.
Zurück zum Zitat Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, Horie H, Kaneko M, Sasaki F, Hashizume K, Nakagawara A, Ohnuma N, Yokoyama T: High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer 2004,91(5):972–979.PubMedCentralPubMed Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, Horie H, Kaneko M, Sasaki F, Hashizume K, Nakagawara A, Ohnuma N, Yokoyama T: High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer 2004,91(5):972–979.PubMedCentralPubMed
2.
Zurück zum Zitat Wang LL, Filippi RZ, Zurakowski D, Archibald T, Vargas SO, Voss SD, Shamberger RC, Davies K, Kozakewich H, Perez-Atayde AR: Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010,34(3):287–299. 10.1097/PAS.0b013e3181ce5f1ePubMedCrossRef Wang LL, Filippi RZ, Zurakowski D, Archibald T, Vargas SO, Voss SD, Shamberger RC, Davies K, Kozakewich H, Perez-Atayde AR: Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010,34(3):287–299. 10.1097/PAS.0b013e3181ce5f1ePubMedCrossRef
3.
Zurück zum Zitat Hou JY, Liu HC, Yeh TC, Chen SH, Wang LY, Sheu JC, Liang DC: Long-term treatment results of hepatoblastoma at a single institution in Taiwan. J Pediatr Hematol Oncol 2009,31(10):718–722. 10.1097/MPH.0b013e3181b6db88PubMedCrossRef Hou JY, Liu HC, Yeh TC, Chen SH, Wang LY, Sheu JC, Liang DC: Long-term treatment results of hepatoblastoma at a single institution in Taiwan. J Pediatr Hematol Oncol 2009,31(10):718–722. 10.1097/MPH.0b013e3181b6db88PubMedCrossRef
4.
Zurück zum Zitat Sakamoto LH, DE Camargo B, Cajaiba M, Soares FA, Vettore AL: MT1G hypermethylation: a potential prognostic marker for hepatoblastoma. Pediatr Res 2010,67(4):387–393. 10.1203/PDR.0b013e3181d01863PubMedCrossRef Sakamoto LH, DE Camargo B, Cajaiba M, Soares FA, Vettore AL: MT1G hypermethylation: a potential prognostic marker for hepatoblastoma. Pediatr Res 2010,67(4):387–393. 10.1203/PDR.0b013e3181d01863PubMedCrossRef
5.
Zurück zum Zitat Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M: Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg 2010,45(2):387–392. 10.1016/j.jpedsurg.2009.10.081PubMedCrossRef Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M: Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg 2010,45(2):387–392. 10.1016/j.jpedsurg.2009.10.081PubMedCrossRef
6.
Zurück zum Zitat von Schweinitz D, Kraus JA, Albrecht S, Koch A, Fuchs J, Pietsch T: Prognostic impact of molecular genetic alterations in hepatoblastoma. Med Pediatr Oncol 2002,38(2):104–108. 10.1002/mpo.1280PubMedCrossRef von Schweinitz D, Kraus JA, Albrecht S, Koch A, Fuchs J, Pietsch T: Prognostic impact of molecular genetic alterations in hepatoblastoma. Med Pediatr Oncol 2002,38(2):104–108. 10.1002/mpo.1280PubMedCrossRef
7.
Zurück zum Zitat Weber RG, Pietsch T, von Schweinitz D, Lichter P: Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000,157(2):571–578. 10.1016/S0002-9440(10)64567-1PubMedCentralPubMedCrossRef Weber RG, Pietsch T, von Schweinitz D, Lichter P: Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000,157(2):571–578. 10.1016/S0002-9440(10)64567-1PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, Sato N, Kubo M, Kuroki S, Tanaka M, Katano M: The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res 2009,29(3):871–879.PubMed Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, Sato N, Kubo M, Kuroki S, Tanaka M, Katano M: The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res 2009,29(3):871–879.PubMed
9.
Zurück zum Zitat Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY, Cheung AN: Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 2009,30(1):131–140.PubMedCrossRef Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY, Cheung AN: Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 2009,30(1):131–140.PubMedCrossRef
10.
Zurück zum Zitat Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M, Tsujimura T, Hashimoto-Tamaoki T, Fujiwara Y: Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. Br J Cancer 2008,98(10):1670–1674. 10.1038/sj.bjc.6604361PubMedCentralPubMedCrossRef Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M, Tsujimura T, Hashimoto-Tamaoki T, Fujiwara Y: Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. Br J Cancer 2008,98(10):1670–1674. 10.1038/sj.bjc.6604361PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Lauth M, Toftgård R: The Hedgehog pathway as a drug target in cancer therapy. Curr Opin Investig Drugs 2007,8(6):457–461.PubMed Lauth M, Toftgård R: The Hedgehog pathway as a drug target in cancer therapy. Curr Opin Investig Drugs 2007,8(6):457–461.PubMed
12.
Zurück zum Zitat Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, Hammond GD: Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989,64(5):1082–1095. 10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-GPubMedCrossRef Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, Hammond GD: Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989,64(5):1082–1095. 10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-GPubMedCrossRef
13.
Zurück zum Zitat Zhang D, Qiu L, Jin X, Guo Z, Guo C: Nuclear factorkappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Mol Cancer Res 2009,7(7):1139–1149. 10.1158/1541-7786.MCR-08-0410PubMedCrossRef Zhang D, Qiu L, Jin X, Guo Z, Guo C: Nuclear factorkappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Mol Cancer Res 2009,7(7):1139–1149. 10.1158/1541-7786.MCR-08-0410PubMedCrossRef
14.
Zurück zum Zitat Yagui-Beltrán A, He B, Raz D, Kim J, Jablons DM: Novel therapies targeting signaling pathways in lung cancer. Thorac Surg Clin 2006,16(4):379–396. 10.1016/j.thorsurg.2006.07.001PubMedCrossRef Yagui-Beltrán A, He B, Raz D, Kim J, Jablons DM: Novel therapies targeting signaling pathways in lung cancer. Thorac Surg Clin 2006,16(4):379–396. 10.1016/j.thorsurg.2006.07.001PubMedCrossRef
15.
Zurück zum Zitat Mori Y, Okumura T, Tsunoda S, Sakai Y, Shimada Y: Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology 2006,70(5):378–389. 10.1159/000098111PubMedCrossRef Mori Y, Okumura T, Tsunoda S, Sakai Y, Shimada Y: Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology 2006,70(5):378–389. 10.1159/000098111PubMedCrossRef
16.
Zurück zum Zitat Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T, Konishi I: Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis. Cancer Sci 2007,98(1):68–76. 10.1111/j.1349-7006.2006.00353.xPubMedCrossRef Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T, Konishi I: Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis. Cancer Sci 2007,98(1):68–76. 10.1111/j.1349-7006.2006.00353.xPubMedCrossRef
17.
Zurück zum Zitat Ferretti E, Di Marcotullio L, Gessi M, Mattei T, Greco A, Po A, De Smaele E, Giangaspero F, Riccardi R, Di Rocco C, Pazzaglia S, Maroder M, Alimandi M, Screpanti I, Gulino A: Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. Oncogene 2006,25(55):7267–7273. 10.1038/sj.onc.1209716PubMedCrossRef Ferretti E, Di Marcotullio L, Gessi M, Mattei T, Greco A, Po A, De Smaele E, Giangaspero F, Riccardi R, Di Rocco C, Pazzaglia S, Maroder M, Alimandi M, Screpanti I, Gulino A: Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. Oncogene 2006,25(55):7267–7273. 10.1038/sj.onc.1209716PubMedCrossRef
18.
Zurück zum Zitat Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernández-Zapico ME, Hanahan D: GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 2009,23(1):24–36. 10.1101/gad.1753809PubMedCentralPubMedCrossRef Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernández-Zapico ME, Hanahan D: GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 2009,23(1):24–36. 10.1101/gad.1753809PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Yoshizaki A, Nakayama T, Naito S, Wen CY, Sekine I: Expressions of sonic hedgehog, patched, smoothened and Gli-1 in human intestinal stromal tumors and their correlation with prognosis. World J Gastroenterol 2006,12(35):5687–5691.PubMedCentralPubMed Yoshizaki A, Nakayama T, Naito S, Wen CY, Sekine I: Expressions of sonic hedgehog, patched, smoothened and Gli-1 in human intestinal stromal tumors and their correlation with prognosis. World J Gastroenterol 2006,12(35):5687–5691.PubMedCentralPubMed
20.
Zurück zum Zitat Kim KH, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Chung YS, Kim SH: Expression of sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium. Pathol Int 2009,59(5):279–287. 10.1111/j.1440-1827.2009.02366.xPubMedCrossRef Kim KH, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Chung YS, Kim SH: Expression of sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium. Pathol Int 2009,59(5):279–287. 10.1111/j.1440-1827.2009.02366.xPubMedCrossRef
21.
Zurück zum Zitat Hochman E, Castiel A, Jacob-Hirsch J, Amariglio N, Izraeli S: Molecular pathways regulating pro-migratory effects of Hedgehog signaling. J Biol Chem 2006,281(45):33860–33870. 10.1074/jbc.M605905200PubMedCrossRef Hochman E, Castiel A, Jacob-Hirsch J, Amariglio N, Izraeli S: Molecular pathways regulating pro-migratory effects of Hedgehog signaling. J Biol Chem 2006,281(45):33860–33870. 10.1074/jbc.M605905200PubMedCrossRef
22.
Zurück zum Zitat Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, Reich R: Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? Cancer Metastasis Rev 2003,22(1):103–115. 10.1023/A:1022272204045PubMedCrossRef Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, Reich R: Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? Cancer Metastasis Rev 2003,22(1):103–115. 10.1023/A:1022272204045PubMedCrossRef
23.
Zurück zum Zitat Sodek KL, Ringuette MJ, Brown TJ: MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells. Br J Cancer 2007,97(3):358–367. 10.1038/sj.bjc.6603863PubMedCentralPubMedCrossRef Sodek KL, Ringuette MJ, Brown TJ: MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells. Br J Cancer 2007,97(3):358–367. 10.1038/sj.bjc.6603863PubMedCentralPubMedCrossRef
Metadaten
Titel
Prognostic value of hedgehog signal component expressions in hepatoblastoma patients
verfasst von
Ying-Cun Li
Yu-Hua Deng
Zhen-Hua Guo
Ming-Man Zhang
Jin Zhu
Chon-Lun Pu
Chun-Ping Xiang
Chun-Bao Guo
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
European Journal of Medical Research / Ausgabe 11/2010
Elektronische ISSN: 2047-783X
DOI
https://doi.org/10.1186/2047-783X-15-11-468

Weitere Artikel der Ausgabe 11/2010

European Journal of Medical Research 11/2010 Zur Ausgabe